Citron Still Thinks Mobileye Is Way Overvalued By: Benzinga via Benzinga January 06, 2016 at 10:54 AM EST Noted short-selling arm, Citron Research, has not pulled any punches on Mobileye NV (NYSE: MBLY). Left: Stock Still Way ... Read More >> Related Stocks: Bio-Techne Corp CI First Asset Core US Equity ETF General Motors Volkswagen A G ADR